News
QIAGEN Expands Tuberculosis Portfolio With New NGS Panel To Support Real-Time Surveillance And Combat Antimicrobial Resistance
24 Apr 24
Biotech, News, General
QIAGEN Partners With International Panel Physicians Association To Increase Awareness Of Tuberculosis Screening Requirements
18 Mar 24
Biotech, News, General
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $52
8 Feb 24
News, Price Target, Analyst Ratings
Citigroup Maintains Buy on Qiagen, Lowers Price Target to $60
8 Feb 24
News, Price Target, Analyst Ratings
QIAGEN Sees FY24 EPS $2.10 CER Vs $2.20 CER Est.; Revenue Of At Least $2B CER Vs 2.06B CER Est.
6 Feb 24
News, Guidance
Qiagen Q4 EPS $0.55 Beats $0.53 Estimate, Sales $503.00M Beat $501.28M Estimate
6 Feb 24
Earnings, Earnings Beats, News
Earnings Scheduled For February 6, 2024
6 Feb 24
Earnings
Earnings Preview: Qiagen
5 Feb 24
Earnings
Press releases
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
24 Apr 24
Press Releases
QIAGEN N.V. to release results for Q1 2024 and hold webcast
9 Apr 24
Press Releases
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
3 Apr 24
Press Releases
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare system
25 Mar 24
Press Releases
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirements
18 Mar 24
Press Releases
QIAGEN announces Form 20-F annual report filing for 2023 results
11 Mar 24
Press Releases
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
27 Feb 24
Press Releases